Self-administered C1 esterase inhibitor concentrates for the management of hereditary angioedema: usability and patient acceptance

References

• BorkKMengGStaubachPHardtJHereditary angioedema: new findings concerning symptoms, affected organs, and courseAm J Med2006119326727416490473
   PubMed Web of Science ®Google Scholar
• WilliamsAHCraigTJPerioperative management for patients with hereditary angioedemaAllergy Rhinol (Providence)201561505525860171
   PubMedGoogle Scholar
• ZanichelliAArcoleoFBarcaMPA nationwide survey of hereditary angioedema due to C1 inhibitor deficiency in ItalyOrphanet J Rare Dis2015101125758562
   PubMed Web of Science ®Google Scholar
• ZurawBLClinical practice. Hereditary angioedemaN Engl J Med2008359101027103618768946
   PubMed Web of Science ®Google Scholar
• BernsteinJAUpdate on angioedema: evaluation, diagnosis, and treatmentAllergy Asthma Proc201132640841222221433
   PubMed Web of Science ®Google Scholar
• HAE db [webpage on the Internet]C1 inhibitor gene mutation database Available from: http://hae.enzim.hu/stat.phpAccessed January 6, 2016
   Google Scholar
• RosenFSAlperCAPenskyJKlempererMRDonaldsonVHGenetically determined heterogeneity of the C1 esterase inhibitor in patients with hereditary angioneurotic edemaJ Clin Invest19715010214321494107267
   PubMed Web of Science ®Google Scholar
• RosenFSPenskyJDonaldsonVCharachePHereditary angioneurotic edema: two genetic variantsScience1965148367295795814277836
   PubMed Web of Science ®Google Scholar
• CugnoMNussbergerJCicardiMAgostoniABradykinin and the pathophysiology of angioedemaInt Immunopharmacol20033331131712639808
   PubMed Web of Science ®Google Scholar
• NussbergerJCugnoMCicardiMAgostoniALocal bradykinin generation in hereditary angioedemaJ Allergy Clin Immunol199910461321132210589018
   PubMed Web of Science ®Google Scholar
• BorkKPasteurized and nanofiltered, plasma-derived C1 esterase inhibitor concentrate for the treatment of hereditary angioedemaImmunotherapy20146553355124635050
   PubMed Web of Science ®Google Scholar
• BorkKHardtJSchicketanzKHResselNClinical studies of sudden upper airway obstruction in patients with hereditary angioedema due to C1 esterase inhibitor deficiencyArch Intern Med2003163101229123512767961
   PubMedGoogle Scholar
• BorkKHereditary angioedema with normal C1 inhibitor activity including hereditary angioedema with coagulation factor XII gene mutationsImmunol Allergy Clin North Am200626470972417085286
   PubMed Web of Science ®Google Scholar
• Aygören-PürsünEBygumABeusterienKSocioeconomic burden of hereditary angioedema: results from the hereditary angioedema burden of illness study in EuropeOrphanet J Rare Dis201499924996814
   PubMed Web of Science ®Google Scholar
• CaballeroTAygören-PürsünEBygumAThe humanistic burden of hereditary angioedema: results from the Burden of Illness Study in EuropeAllergy Asthma Proc2014351475324268449
   PubMed Web of Science ®Google Scholar
• GompelsMMLockRJAbinunMC1 inhibitor deficiency: consensus documentClin Exp Immunol2005139337939415730382
   PubMed Web of Science ®Google Scholar
• FrankMMGelfandJAAtkinsonJPHereditary angioedema: the clinical syndrome and its managementAnn Intern Med19768455805931275365
   PubMed Web of Science ®Google Scholar
• BorkKSiedleckiKBoschSSchopfREKreuzWAsphyxiation by laryngeal edema in patients with hereditary angioedemaMayo Clin Proc200075434935410761488
   PubMed Web of Science ®Google Scholar
• CicardiMAgostoniAHereditary angioedemaN Engl J Med199633425166616678628365
   PubMed Web of Science ®Google Scholar
• AliMABorumMLHereditary angioedema: what the gastroenterologist needs to knowClin Exp Gastroenterol2014743544525429234
   PubMedGoogle Scholar
• BorkKHardtJStaubach-RenzPWitzkeGRisk of laryngeal edema and facial swellings after tooth extraction in patients with hereditary angioedema with and without prophylaxis with C1 inhibitor concentrate: a retrospective studyOral Surg Oral Med Oral Pathol Oral Radiol Endod20111121586421601496
   PubMed Web of Science ®Google Scholar
• ZotterZCsukaDSzaboEThe influence of trigger factors on hereditary angioedema due to C1-inhibitor deficiencyOrphanet J Rare Dis201494424678771
   PubMed Web of Science ®Google Scholar
• MorcavalloPSLeonidaARossiGHereditary angioedema in oral surgery: overview of the clinical picture and report of a caseJ Oral Maxillofac Surg20106892307231120728035
   PubMed Web of Science ®Google Scholar
• HuangSWResults of an on-line survey of patients with hereditary angioedemaAllergy Asthma Proc200425212713115176498
   PubMed Web of Science ®Google Scholar
• GomideMAToledoEValleSOHereditary angioedema: quality of life in Brazilian patientsClinics (Sao Paulo)2013681818323420162
   PubMed Web of Science ®Google Scholar
• LumryWRCastaldoAJVernonMKBlausteinMBWilsonDAHornPTThe humanistic burden of hereditary angioedema: impact on health-related quality of life, productivity, and depressionAllergy Asthma Proc201031540741420929608
   PubMed Web of Science ®Google Scholar
• WilsonDABorkKSheaEPRentzAMBlausteinMBPullmanWEEconomic costs associated with acute attacks and long-term management of hereditary angioedemaAnn Allergy Asthma Immunol2010104431432020408341
   PubMed Web of Science ®Google Scholar
• BouilletLLaunayDFainOHereditary angioedema with C1 inhibitor deficiency: clinical presentation and quality of life of 193 French patientsAnn Allergy Asthma Immunol2013111429029424054366
   PubMed Web of Science ®Google Scholar
• ZurawBLBanerjiABernsteinJAUS Hereditary Angioedema Association Medical Advisory Board 2013 recommendations for the management of hereditary angioedema due to C1 inhibitor deficiencyJ Allergy Clin Immunol Pract20131545846724565617
   PubMed Web of Science ®Google Scholar
• BowenTCicardiMFarkasH2010 International consensus algorithm for the diagnosis, therapy and management of hereditary angioedemaAllergy Asthma Clin Immunol201062420667127
   PubMedGoogle Scholar
• BowenTHereditary angioedema: beyond international consensus – circa December 2010 – The Canadian Society of Allergy and Clinical Immunology Dr. David McCourtie LectureAllergy Asthma Clin Immunol20117121310025
   PubMed Web of Science ®Google Scholar
• CSL Behring Ltd [webpage on the Internet]Full Prescribing Information. Berniert [C1 Esterase Inhibitor (Human)] Available from: http://labeling.cslbehring.com/PI/US/Berinert/EN/Berinert-Prescribing-Information.pdfAccessed January 20, 2016
   Google Scholar
• US Food Drug AdministrationOctober 9, 2009, Approval Letter - Berinert2009 http://www.fda.gov/BiologicsBloodVaccines/Blood-BloodProducts/ApprovedProducts/LicensedProductsBLAs/FractionatedPlasmaProducts/ucm186265.htmAccessed January 6, 2015
   Google Scholar
• European Medicines AgencyCinryze (C1 Inhibitor (Human))CHMP Assessment Report for Paediatric Use Studies Submitted According to Article 46 of the Regulation (EC) No 1901/20062013 http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Assessment_Report_-_Variation/human/001207/WC500152686.pdfAccessed January 6, 2015
   Google Scholar
• US Food and Drug AdministrationOctober 10, 2008, Approval Letter - CINRYZE 2008 http://www.fda.gov/biologicsbloodvaccines/bloodbloodproducts/approvedproducts/licensedproductsblas/fractionatedplasmaproducts/ucm093602.htmAccessed January 6, 2016
   Google Scholar
• Sanquin Ltd. CetorPatient Information http://www.haenet.hu/doc/patient/Cetor%20Patient%20information.pdfAccessed January 6, 2016
   Google Scholar
• European Medicines Agency [webpage on the Internet]Assessment Report: Cinryze2011 http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Public_assessment_report/human/001207/WC500108898.pdfAccessed January 6, 2015
   Google Scholar
• Shire Medical Information [webpage on the Internet]Cinryze® (C1 Esterase Inhibitor [Human]). Highlights of Prescribing Information Available from: http://pi.shirecontent.com/PI/PDFs/Cinryze_USA_ENG.pdfAccessed October 18, 2015
   Google Scholar
• Pharming Group NV [webpage on the Internet]Ruconest 2100 U Powder for Solution for Injection. Summary of Product Characteristics Available from: http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/001223/WC500098542.pdfAccessed March 7, 2016
   Google Scholar
• Pharming Group NV [webpage on the Internet]Medical Information. Ruconest® (C1 Esterase Inhibitor [Recombinant]). Highlights of Prescribing Information Available from: http://shared.salix.com/shared/pi/ruconest-pi.pdfAccessed March 7, 2016
   Google Scholar
• Dyax Medical Information [webpage on the Internet]Kalbitor® (ecallantide). Highlights of Prescribing Information2015 Available from: https://www.kalbitor.com/hcp/rems/pdf/KalbitorFullPrescribingInformation.pdfAccessed March 7, 2016
   Google Scholar
• Shire Orphan Therapies GmbH [webpage on the Internet]Firazyr 30 mg Solution for Injection in Pre-Filled Syringe. Summary of Product Characteristics Available from: http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/000899/WC500022966.pdfAccessed March 7, 2016
   Google Scholar
• Shire Medical Information [webpage on the Internet]Firazyr® (icatibant). Highlights of Prescribing Information Available from: http://pi.shirecontent.com/PI/PDFs/Firazyr_USA_ENG.pdfAccessed March 7, 2016
   Google Scholar
• BorkKSteffensenIMachnigTTreatment with C1-esterase inhibitor concentrate in type I or II hereditary angioedema: a systematic literature reviewAllergy Asthma Proc201334431232723710659
   PubMed Web of Science ®Google Scholar
• ZurawBLBussePJWhiteMNanofiltered C1 inhibitor concentrate for treatment of hereditary angioedemaN Engl J Med2010363651352220818886
   PubMed Web of Science ®Google Scholar
• GrantJAWhiteMVLiHHPreprocedural administration of nanofiltered C1 esterase inhibitor to prevent hereditary angioedema attacksAllergy Asthma Proc201233434835322856635
   PubMed Web of Science ®Google Scholar
• LumryWRMillerDPNewcomerSFittsDDaynoJQuality of life in patients with hereditary angioedema receiving therapy for routine prevention of attacksAllergy Asthma Proc201435537137625295804
   PubMed Web of Science ®Google Scholar
• ZurawBLKalfusISafety and efficacy of prophylactic nanofiltered C1-inhibitor in hereditary angioedemaAm J Med20121259938.e1938.e722800873
   PubMed Web of Science ®Google Scholar
• BernsteinJAManningMELiHEscalating doses of C1 esterase inhibitor (CINRYZE) for prophylaxis in patients with hereditary angioedemaJ Allergy Clin Immunol Pract201421778424565773
   PubMed Web of Science ®Google Scholar
• FarkasHZotterZCsukaDShort-term prophylaxis in hereditary angioedema due to deficiency of the C1-inhibitor – a long-term surveyAllergy201267121586159323025435
   PubMed Web of Science ®Google Scholar
• KreuzWMartinez-SaguerIAygören-PürsünERusickeEHellerCKlingebielTC1-inhibitor concentrate for individual replacement therapy in patients with severe hereditary angioedema refractory to danazol prophylaxisTransfusion20094991987199519497056
   PubMed Web of Science ®Google Scholar
• BorkKMengGStaubachPHardtJTreatment with C1 inhibitor concentrate in abdominal pain attacks of patients with hereditary angioedemaTransfusion200545111774178416271103
   PubMed Web of Science ®Google Scholar
• BorkKStaubachPHardtJTreatment of skin swellings with C1-inhibitor concentrate in patients with hereditary angio-oedemaAllergy200863675175718445189
   PubMed Web of Science ®Google Scholar
• LeviMChoiGPicavetCHackCESelf-administration of C1-inhibitor concentrate in patients with hereditary or acquired angioedema caused by C1-inhibitor deficiencyJ Allergy Clin Immunol2006117490490816630950
   PubMed Web of Science ®Google Scholar
• KreuzWRusickeEMartinez-SaguerIAygören-PürsünEHellerCKlingebielTHome therapy with intravenous human C1-inhibitor in children and adolescents with hereditary angioedemaTransfusion201252110010721756262
   PubMed Web of Science ®Google Scholar
• BygumAAndersenKEMikkelsenCSSelf-administration of intravenous C1-inhibitor therapy for hereditary angioedema and associated quality of life benefitsEur J Dermatol200919214715119264579
   PubMed Web of Science ®Google Scholar
• Aygören-PürsünEMartinez-SaguerIRusickeEKlingebielTKreuzWOn demand treatment and home therapy of hereditary angioedema in Germany – the Frankfurt experienceAllergy Asthma Clin Immunol201062120667124
   PubMedGoogle Scholar
• LonghurstHJCarrSKhairKC1-inhibitor concentrate home therapy for hereditary angioedema: a viable, effective treatment optionClin Exp Immunol20071471111717177958
   PubMed Web of Science ®Google Scholar
• TourangeauLMCastaldoAJDavisDKKoziolJChristiansenSCZurawBLSafety and efficacy of physician-supervised self-managed C1 inhibitor replacement therapyInt Arch Allergy Immunol2012157441742422123229
   PubMed Web of Science ®Google Scholar
• CaballeroTBaezaMLCabañasRConsensus statement on the diagnosis, management, and treatment of angioedema mediated by bradykinin. Part I. Classification, epidemiology, pathophysiology, genetics, clinical symptoms, and diagnosisJ Investig Allergol Clin Immunol2011215333347 quiz follow 347
   PubMed Web of Science ®Google Scholar
• CicardiMBorkKCaballeroTEvidence-based recommendations for the therapeutic management of angioedema owing to hereditary C1 inhibitor deficiency: consensus report of an International Working GroupAllergy201267214715722126399
   PubMed Web of Science ®Google Scholar
• CraigTAygören-PürsünEBorkKWAO guideline for the management of hereditary angioedemaWorld Allergy Organ J201251218219923282420
   PubMedGoogle Scholar
• WahnVAbererWEberlWHereditary angioedema (HAE) in children and adolescents – a consensus on therapeutic strategiesEur J Pediatr201217191339134822543566
   PubMed Web of Science ®Google Scholar
• RiedlMGowerRGChrvalaCACurrent medical management of hereditary angioedema: results from a large survey of US physiciansAnn Allergy Asthma Immunol20111064316.e4322.e421457880
   PubMed Web of Science ®Google Scholar
• US Food and Drug Administration [webpage on the Internet]Cinryze [C1 Inhibitor (Human)] Freeze Dried Powder US Prescribing Information2011 Available from: http://www.fda.gov/downloads/BiologicsBloodVaccines/BloodBloodProducts/ApprovedProducts/LicensedProductsBLAs/FractionatedPlasmaProducts/UCM129918.pdfAccessed January 20, 2015
   Google Scholar
• UK Medicines Information [webpage on the Internet]New Drugs Online Report for C1 Inhibitor (Human) Available from: http://www.ukmi.nhs.uk/applications/ndo/record_view_open.asp?newDrugID=4234Accessed January 6, 2016
   Google Scholar
• European Medicines Agency [webpage on the Internet]Cinryze 500 Units Powder and Solvent for Solutions for Injection: Summary of Product Characteristics2011 Available from: http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/001207/WC500108895.pdfAccessed January 6, 2016
   Google Scholar
• LandmesserLTillotsonGMarianoDSite of care of nanofiltered C1 esterase inhibitor [human] (nf-C1INH) in patients with hereditary angioedema (HAE)American College of Clinical Pharmacy Annual Meeting30Austin, TexasPharmacotherapy2010456e Abstract 324
   Google Scholar
• GregoryCLandmesserLMCorriganLMarianoDFeasibility of home infusion and self-administration of nanofiltered C1 esterase inhibitor for routine prophylaxis in patients with hereditary angioedema and characterization of a training and support programJ Infus Nurs2014371293424384882
   PubMedGoogle Scholar
• CSL Behring LtdImportant Safety Information. Berinert [C1 Esterase Inhibitor (Human)] http://www.berinert.com/professional/important-safety-information.aspxAccessed January 6, 2016
   Google Scholar
• Shire PlcImportant safety informationCinryzeC1 Esterase Inhibitor (Human) http://www.cinryze.com/Accessed January 6, 2016
   Google Scholar
• Sanquin LtdSummary of Product Characteristics (Cetor 100 U/ml powder and solvent for solution for injection) http://www.sanquin.nl/repository/documenten/en/prod-en-dienst/plasmaproducten/139660/Summary_of_Product_Characteristics.pdfAccessed January 6, 2016
   Google Scholar
• Sanquin LtdPackage Leaflet Information for the User. Cetor 500 U Powder and Solvent for Solution for Injection http://www.sanquin.nl/repository/documenten/en/prod-en-dienst/plasmaproducten/139660/Package_Leaflet.pdfAccessed January 6, 2016
   Google Scholar
• Aygören-PürsünEMagerlMMartinez-SaguerICharacterising the safety and use of C1 inhibitor in routine clinical practice: interim results from a European Registry studyEuropean Academy of Allergy and Clinical Immunology CongressBarcelona, Spain2015
   Google Scholar
• BussePBygumAEdelmanJSafety of C1-esterase inhibitor in acute and prophylactic therapy of hereditary angioedema: findings from the ongoing international Berinert patient registryJ Allergy Clin Immunol Pract20153221321925609333
   PubMed Web of Science ®Google Scholar
• ReadNLimETarziMDHildick-SmithPBurnsSFidlerKJPaediatric hereditary angioedema: a survey of UK service provision and patient experienceClin Exp Immunol2014178348348825113655
   PubMed Web of Science ®Google Scholar
• DalyPBEvansJHKobayashiRHHome-based immunoglobulin infusion therapy: quality of life and patient health perceptionsAnn Allergy19916755045101958004
   PubMedGoogle Scholar
• GardulfANicolayUMathDChildren and adults with primary antibody deficiencies gain quality of life by subcutaneous IgG self-infusions at homeJ Allergy Clin Immunol2004114493694215480339
   PubMed Web of Science ®Google Scholar
• RosendaalFRSmitCVarekampIModern haemophilia treatment: medical improvements and quality of lifeJ Intern Med199022866336402280241
   PubMed Web of Science ®Google Scholar
• SymonsCRossiOMagerlMAndritschkeKPractical approach to self-administration of intravenous C1-INH concentrate: a nursing perspectiveInt Arch Allergy Immunol2013161suppl 1172023689240
   PubMed Web of Science ®Google Scholar
• ShapiroRIntravenous self-administration of C1-INH concentrate for hereditary angioedema: a retrospective report of real-world experience in 13 patientsJ Angioedema20131228
   Google Scholar
• LonghurstHJFarkasHCraigTHAE international home therapy consensus documentAllergy Asthma Clin Immunol201062220667125
   PubMedGoogle Scholar
• BoysenHBBouilletLAygören-PürsünEChallenges of C1-inhibitor concentrate self-administrationInt Arch Allergy Immunol2013161suppl 1212523689241
   PubMed Web of Science ®Google Scholar
• GowerRGLumryWRDavis-LortonMAJohnstonDTBussePJCurrent options for prophylactic treatment of hereditary angioedema in the United States: patient-based considerationsAllergy Asthma Proc201233323524022584192
   PubMed Web of Science ®Google Scholar
• ClinicalTrials.gov [webpage on the Internet]A Study to Evaluate the Clinical Efficacy and Safety of Subcutaneously Administered C1-Esterase Inhibitor for the Prevention of Angioedema Attacks in Adolescents and Adults with Hereditary Angioedema2015 NCT02584959. Available from: www.ClinicalTrials.gov/ct2/show/NCT02584959Accessed January 6, 2016
   Google Scholar
• ZurawBLCicardiMLonghurstHJPhase II study results of a replacement therapy for hereditary angioedema with subcutaneous C1-inhibitor concentrateAllergy201570101319132826016741
   PubMed Web of Science ®Google Scholar
• ClinicalTrials.gov [webpage on the Internet]A Study to Evaluate the Clinical Efficacy and Safety of Subcutaneously Administered C1-Esterase Inhibitor in the Prevention of Hereditary Angioedema2013 NCT01912456. Available from: www.ClinicalTrials.gov/ct2/show/NCT01912456Accessed January 6, 2016
   Google Scholar